Dana-Farber Cancer Institute Business Development Manager Salary
The average Dana-Farber Cancer Institute Business Development Manager earns an estimated $171,176 annually, which includes an estimated base salary of $143,676 with a $27,500 bonus. Dana-Farber Cancer Institute's Business Development Manager compensation is $39,035 more than the US average for a Business Development Manager. Business Development Manager salaries at Dana-Farber Cancer Institute can range from $135,000 - $202,500.
The Business Development Department at Dana-Farber Cancer Institute earns $5,506 more on average than the Finance Department.
Last updated 7 months ago.
- $143,676
- avg. base
- $27,500
- avg. bonus
Business Development Manager Salaries at Dana-Farber Cancer Institute
Business Development Managers earn $86,973 more than Account Managers, and $660 less than Business Development Managers.
Compensation at Dana-Farber Cancer Institute by Department
The Business Development Department averages $5,506 more than the Finance Department, and $3,314 less than the Marketing Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to Dana-Farber Cancer Institute reported making $126,047, while the average male Business Development Manager at similar sized companies reported making $134,824.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Native American Business Development Manager at companies similar size to Dana-Farber Cancer Institute reported making $195,000, while the average African American/Black Business Development Manager at similar sized companies reported making $88,600.
How Business Development Managers at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Business Development Managers at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Business Development Managers at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
